Literature DB >> 21244299

The promise of deep brain stimulation in X-linked dystonia parkinsonism.

Jose A Aguilar1, Theodor S Vesagas, Roland Dominic Jamora, Rosalia A Teleg, Lourdes Ledesma, Raymond L Rosales, Hubert H Fernandez, Lillian V Lee.   

Abstract

X-Linked dystonia parkinsonism (XDP) is a rapidly progressive and disabling neurodegenerative disease affecting mainly male Filipinos with origins from Panay Island. We reviewed all the past neurosurgical ablative procedures done for XDP patients listed in the Philippine XDP registry. From 1960 to 1982, six patients had undergone bilateral chemopallidotomies or bilateral thalomotomies staged over time. Half of these patients had significant improvement in their symptoms but five of the six patients (83%) developed postoperative morbidities, mainly speech impairment or hemiparesis. All the five reported GPi deep brain stimulation (DBS) cases for XDP were also reviewed, showing consistently immediate improvement of symptoms (61.5%-88.3% decrease in the Burke-Marsden-Fahn Dystonia Rating Scale) lasting up to a year with no adverse effects noted. We also present the first Philippine case of GPi DBS done in the youngest XDP patient to date. This present case showed dramatic improvement (88.3% decrease of the Burke-Marsden-Fahn Dystonia Rating Scale) of his dystonic symptoms, without incurring any persistent adverse effects. The results of these early cases of pallidal DBS for XDP show that DBS is generally a safe and effective procedure for alleviating the disabling symptoms of XDP in contrast to previous ablative surgeries performed on these patients.

Entities:  

Mesh:

Year:  2011        PMID: 21244299     DOI: 10.3109/00207454.2010.541573

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  10 in total

1.  Association of Pallidal Neurostimulation and Outcome Predictors With X-linked Dystonia Parkinsonism.

Authors:  Norbert Brüggemann; Aloysius Domingo; Dirk Rasche; Christian K E Moll; Raymond L Rosales; Roland Dominic G Jamora; Henrike Hanssen; Alexander Münchau; Julia Graf; Anne Weissbach; Vera Tadic; Cid C Diesta; Jens Volkmann; Andrea Kühn; Thomas F Münte; Volker Tronnier; Christine Klein
Journal:  JAMA Neurol       Date:  2019-02-01       Impact factor: 18.302

Review 2.  Treatment of dystonia.

Authors:  Mary Ann Thenganatt; Joseph Jankovic
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

3.  X-linked Dystonia-Parkinsonism patient cells exhibit altered signaling via nuclear factor-kappa B.

Authors:  Christine A Vaine; David Shin; Christina Liu; William T Hendriks; Jyotsna Dhakal; Kyle Shin; Nutan Sharma; D Cristopher Bragg
Journal:  Neurobiol Dis       Date:  2016-12-22       Impact factor: 5.996

4.  Deep Brain Stimulation for DYT3 Dystonia.

Authors:  Alexander Lehn; Caroline Airey; Sarah Olson; John D O'Sullivan; Richard Boyle
Journal:  Mov Disord Clin Pract       Date:  2014-04-10

Review 5.  X-Linked Dystonia-Parkinsonism: recent advances.

Authors:  D Cristopher Bragg; Nutan Sharma; Laurie J Ozelius
Journal:  Curr Opin Neurol       Date:  2019-08       Impact factor: 5.710

6.  Parkinsonism and dystonia in Lubag disease respond well to high pulse width/low-frequency globus pallidus interna DBS.

Authors:  Joan Miravite; Andres Deik; Matthew Swan; Harini Sarva; Brian Harris Kopell; William Lawrence Severt
Journal:  Neurol Clin Pract       Date:  2015-12

Review 7.  X-linked dystonia parkinsonism: clinical phenotype, genetics and therapeutics.

Authors:  Raymond L Rosales
Journal:  J Mov Disord       Date:  2010-10-30

Review 8.  Clinicopathological Phenotype and Genetics of X-Linked Dystonia-Parkinsonism (XDP; DYT3; Lubag).

Authors:  Toshitaka Kawarai; Ryoma Morigaki; Ryuji Kaji; Satoshi Goto
Journal:  Brain Sci       Date:  2017-06-26

Review 9.  Pallidal Deep Brain Stimulation for Monogenic Dystonia: The Effect of Gene on Outcome.

Authors:  Stephen Tisch; Kishore Raj Kumar
Journal:  Front Neurol       Date:  2021-01-08       Impact factor: 4.003

10.  Decreased N-TAF1 expression in X-linked dystonia-parkinsonism patient-specific neural stem cells.

Authors:  Naoto Ito; William T Hendriks; Jyotsna Dhakal; Christine A Vaine; Christina Liu; David Shin; Kyle Shin; Noriko Wakabayashi-Ito; Marisela Dy; Trisha Multhaupt-Buell; Nutan Sharma; Xandra O Breakefield; D Cristopher Bragg
Journal:  Dis Model Mech       Date:  2016-01-14       Impact factor: 5.758

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.